ArticleBritish journal of cancer2009

Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor.

A Z Dudek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.